Bal Pharma Ltd.

₹107.47

+ 1.12 (1.05%)

04:01 pm - close price

BSE: BALPHARMA

NSE: BALPHARMA

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 3.95Good: 5

🟡

Adjusted EPS

Bad: 3Current: 3.95Good: 6

🟡

Return On Capital Employed (ROCE)

Bad: 10Current: 9.78Good: 20

❌

Current Ratio

Bad: 1Current: 1.05Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 7.92Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 42.57Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 3.95Good: 5

🟡

Adjusted EPS

Bad: 3Current: 3.95Good: 6

🟡

Return On Capital Employed (ROCE)

Bad: 10Current: 9.78Good: 20

❌

Current Ratio

Bad: 1Current: 1.05Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 7.92Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 42.57Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	92.54	81.66	94.63	74.36
Expenditure+	84.85	73.87	85.03	67.89
Other Income+	0.14	0.10	2.45	0.82
Operating Profit	7.70	7.80	9.59	6.46
Interest	3.82	3.66	4.14	4.24
Depreciation and Amortization	2.42	2.96	2.16	2.43
Profit Before Tax	1.60	1.27	5.75	0.62
Tax+	0.63	0.42	0.22	0.36
Net Profit	0.97	0.85	5.53	0.26

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	28121.46	30421.63	33921.96	30308.33	31166.13
Operational Expenses+	25723.53	27896.63	30828.41	27332.35	27955.14
Operating Profit	2397.93	2525.00	3093.55	2975.98	3210.99
Other Income	515.20	94.06	284.82	220.29	192.78
OPM %	8.53	8.30	9.12	9.82	10.30
Depreciation and Amortisation	904.01	912.83	1007.11	977.09	1107.93
Interest	1090.88	1231.38	1466.53	1705.44	1702.45
Profit Before Tax	918.24	474.85	904.73	513.74	593.39
Tax	254.10	268.25	404.86	-195.87	-38.62
Net Profit	561.15	257.18	739.22	721.54	628.36

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	26053.32	31100.58	31983.87	33528.05	37473.58
Liabilities+	26053.32	31100.58	31983.87	33528.05	37473.58

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	2679.55	-153.71	2280.58	2031.51	3083.54
Cash from Investing Activity	-948.48	-2218.23	-1889.09	-1491.69	-2069.94
Cash from Financing Activity	-1722.16	2409.38	-120.63	-784.24	-958.65
Net Cash Flow	8.91	37.44	270.86	-244.42	54.95
Opening Cash & Cash Equivalents	102.35	111.27	148.72	419.58	175.16
Closing Cash & Cash Equivalents	111.26	148.71	419.58	175.16	230.11

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	50.86	50.86	50.86	50.86	50.86	50.86	50.86	50.86	51.23	51.23
Public+	49.14	49.14	49.14	49.14	49.14	49.14	49.14	49.14	48.77	48.77
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	14974	15214	15520	15774	15826	15723	15667	16007	15014	14772

Corporate Actions

120 events in the last 3 years

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	92.54	81.66	94.63	74.36
Expenditure+	84.85	73.87	85.03	67.89
Other Income+	0.14	0.10	2.45	0.82
Operating Profit	7.70	7.80	9.59	6.46
Interest	3.82	3.66	4.14	4.24
Depreciation and Amortization	2.42	2.96	2.16	2.43
Profit Before Tax	1.60	1.27	5.75	0.62
Tax+	0.63	0.42	0.22	0.36
Net Profit	0.97	0.85	5.53	0.26

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	2679.55	-153.71	2280.58	2031.51	3083.54
Cash from Investing Activity	-948.48	-2218.23	-1889.09	-1491.69	-2069.94
Cash from Financing Activity	-1722.16	2409.38	-120.63	-784.24	-958.65
Net Cash Flow	8.91	37.44	270.86	-244.42	54.95
Opening Cash & Cash Equivalents	102.35	111.27	148.72	419.58	175.16
Closing Cash & Cash Equivalents	111.26	148.71	419.58	175.16	230.11

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	26053.32	31100.58	31983.87	33528.05	37473.58
Liabilities+	26053.32	31100.58	31983.87	33528.05	37473.58

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	28121.46	30421.63	33921.96	30308.33	31166.13
Operational Expenses+	25723.53	27896.63	30828.41	27332.35	27955.14
Operating Profit	2397.93	2525.00	3093.55	2975.98	3210.99
Other Income	515.20	94.06	284.82	220.29	192.78
OPM %	8.53	8.30	9.12	9.82	10.30
Depreciation and Amortisation	904.01	912.83	1007.11	977.09	1107.93
Interest	1090.88	1231.38	1466.53	1705.44	1702.45
Profit Before Tax	918.24	474.85	904.73	513.74	593.39
Tax	254.10	268.25	404.86	-195.87	-38.62
Net Profit	561.15	257.18	739.22	721.54	628.36

Ratios

Reported EPS

Bad: 2Current: 3.95Good: 5

🟡

Adjusted EPS

Bad: 3Current: 3.95Good: 6

🟡

Return On Capital Employed (ROCE)

Bad: 10Current: 9.78Good: 20

❌

Current Ratio

Bad: 1Current: 1.05Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 7.92Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 42.57Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 3.95Good: 5

🟡

Adjusted EPS

Bad: 3Current: 3.95Good: 6

🟡

Return On Capital Employed (ROCE)

Bad: 10Current: 9.78Good: 20

❌

Current Ratio

Bad: 1Current: 1.05Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 7.92Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 42.57Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	50.86	50.86	50.86	50.86	50.86	50.86	50.86	50.86	51.23	51.23
Public+	49.14	49.14	49.14	49.14	49.14	49.14	49.14	49.14	48.77	48.77
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	14974	15214	15520	15774	15826	15723	15667	16007	15014	14772

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Corporate Actions

120 events in the last 3 years

Bal Pharma Ltd.

₹107.47

+ 1.12 (1.05%)

04:01 pm - close price

BSE: BALPHARMA

NSE: BALPHARMA

Industry: Pharmaceuticals & Drugs

House: Private

Overview